-
Breast Cancer Research Foundation grants more than $4 million to speed Dana-Farber research
Building on past support, BCRF recently made grants totaling more than $4 million to 12 physician-scientists at Dana-Farber.
-
Defeating treatment-resistant lung cancer
A collaborative, multi-institution team led by Dana-Farber’s David Barbie, MD, received a four-year, $2.5 million grant from the International Association for the Study of Lung Cancer (IASLC) and Lung Cancer Research Foundation (LCRF) for researching a cure for non-small cell lung carcinoma.
-
Tricking the immune system to defeat cancer
The New York Stem Cell Foundation (NYSCF) awarded a five-year, $1.5 million grant to Dana-Farber’s Judith Agudo, PhD, for her work to make cancerous tumors more susceptible to immunotherapies and to protect transplanted organs from attack by the immune system.
-
Carney family remains steadfast in support of breast cancer research
With a recent $1 million gift, the Carney Family Charitable Foundation, led by Trustees Patrick and Lillian Carney, has expanded a legacy of support for breast cancer immuno-oncology research at Dana-Farber Cancer Institute that spans over 20 years.
-
Defy cancer celebration
The Defy Cancer Celebration at Fenway Park on Sunday, March 30, was a day filled with hope, progress, and community. It highlighted the impact and innovation in cancer care and research made possible by gifts to The Dana-Farber Campaign from 2017 to 2024.
-
Martin family’s events surpass $1 million milestone
In January, Dana-Farber celebrated the more than $1 million cumulatively raised by the family of the late Sharon Crowley Martin through events including Derby Day, a Kentucky Derby-themed cocktail watch party.
-
Karen O’Connor and Bruce MacGregor
Karen O’Connor and Bruce MacGregor made a generous $100,000 commitment, renewing their support of melanoma research under the leadership of Rizwan Haq, MD, PhD. Their impactful philanthropy is driving innovative studies in immunotherapy, including those targeting anti-tumor immunity, aiming to uncover new treatments and improve outcomes for melanoma patients worldwide.
-
Laurie H. Glimcher, MD, honored with endowed chair
A generous group of Trustees, colleagues, friends, and supporters contributed over $3 million to establish the chair and commemorate Glimcher’s legacy.
-
Grants spur progress in personalized vaccine and rare lung cancer
California-based Troper Wojcicki Foundation provides nearly $2.2 million to advance innovation at Dana-Farber,
-
Beerman Family Fund fuels next-generation approach to cancer vaccines
Gift may help speed production, reduce cost, and increase personalization of cancer vaccines to be more effective in many types of cancers.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.